Glucagon 1mg Injection

Glucagon 1 mg Injection contains glucagon, a hormone that helps increase blood glucose levels by stimulating the release of stored glucose from the liver. It is used for the emergency treatment of severe hypoglycemia, particularly when a person with diabetes is unable to take glucose safely by mouth.

Depending on the specific product authorization, glucagon may also be used as a diagnostic aid during certain radiological examinations in adults.

The medicine is commonly supplied as powder for solution for injection, with a separate diluent in certain emergency kits. The exact presentation and preparation instructions depend on the manufacturer and product label.

Product Information

Product Name

Glucagon 1 mg Injection

Active Ingredient

Glucagon

Strength

1 mg per vial

Dosage Form

Powder for solution for injection, depending on the product

Therapeutic Category

Hyperglycemic agent

Primary Indication

Emergency treatment of severe hypoglycemia

Other Authorized Use

Selected diagnostic procedures, where approved

Route of Administration

Subcutaneous, intramuscular or intravenous, according to the specific product labeling

Packaging

Confirm vial, diluent and syringe configuration

Prescription Requirement

Subject to local regulations

Ordering and Availability

For Glucagon 1 mg Injection pricing, pack sizes and availability, contact the supplier to verify the exact formulation, manufacturer, included diluent, packaging and current stock.

Availability, product authorization, prescription requirements and import eligibility vary by country. Confirm local regulations and obtain the medicine through an authorized pharmacy or eligible healthcare supplier.

Glucagon 1 mg Injection may be used for:

• Severe Hypoglycemia: Emergency treatment of dangerously low blood glucose when the affected person cannot safely take glucose by mouth.
• Emergency Diabetes Management: Provides an important rescue treatment option for people at risk of severe hypoglycemia.
• Diagnostic Procedures: Certain approved formulations may be used under medical supervision to temporarily reduce gastrointestinal movement during radiological examinations.

Glucagon is an emergency treatment, not a substitute for routine diabetes management or ongoing blood glucose monitoring.

The dose and route of administration depend on the patient's age, weight, clinical condition and the specific product instructions.

Glucagon emergency kits commonly require the powder to be mixed with the supplied diluent immediately before use. Follow the manufacturer's instructions exactly. Do not use a reconstituted solution that is cloudy, discoloured or contains visible particles.

Subcutaneous or intramuscular administration may be permitted for emergency treatment, depending on the product. Intravenous administration is intended for appropriately qualified healthcare professionals under medical supervision.

After administering glucagon for severe hypoglycemia, seek emergency medical assistance. Once the person is fully alert and able to swallow safely, oral carbohydrates may be required to restore glucose levels and reduce the risk of recurrent hypoglycemia.

Do not administer anything by mouth to a person who is unconscious or unable to swallow safely. Follow the supplied emergency instructions and professional medical guidance.

Storage Instructions

Store the unopened product according to the manufacturer's instructions and package leaflet. Storage requirements may differ between brands and presentations.

Check the expiry date and inspect the packaging before use. Reconstituted glucagon from conventional emergency kits generally must be used immediately and any unused portion discarded, in accordance with the product instructions.

Possible side effects include:

• Nausea or vomiting
• Headache
• Temporary changes in heart rate or blood pressure
• Injection-site discomfort
• Allergic reactions, which may be serious but are uncommon

Seek urgent medical attention for breathing difficulties, facial or throat swelling, severe allergic symptoms or persistent deterioration after administration.

Inform the healthcare professional about relevant medical conditions, allergies and current medicines whenever possible.

Glucagon may be contraindicated in people with pheochromocytoma, insulinoma or known hypersensitivity to the product's ingredients. It may be less effective in people with significantly depleted liver glycogen stores, such as in certain cases of prolonged fasting or chronic hypoglycemia.

After emergency use, blood glucose may fall again. Appropriate monitoring, carbohydrate replacement when safe, and medical evaluation are important.

Use only the diluent supplied or specifically approved for the product. Do not reuse single-dose vials or retain unused reconstituted solution.